Long-Term Safety Of PF-00547659 In Ulcerative Colitis

NCT01771809 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: 75mg SHP647 (PF-00547659)
DRUG: 225mg SHP647 (PF-00547659)

Sponsor

Shire